Sort
16,300 grants matching “fatty liver disease”
Molecular Biophysics of Mitochondrial Membranes
$696,640Yuriy Kirichok · Washington University · R35 · FY2024 · GM
Human adipose tissue in control of sympathetic tone and metabolic rate
$696,393Silvia Corvera · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · DK
Guided imagery lifestyle intervention to prevent & treat obesity in Latino youth
$696,391Marc J Weigensberg · University Of Southern California · R01 · FY2014 · AT
Community Engagement Core
$696,179Michele D Kipke · Children'S Hospital Of Los Angeles · P50 · FY2025 · MD
A new mouse model for studying the pathogenesis and immunobiology of intrahepatic cholangiocarcinoma and improving its immunotherapy
$695,955Michael Karin · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA
Targeting hepatic mitochondrial function in humans with NAFLD using insulin sensitizers
$695,911Luke Norton · University Of Texas Hlth Science Center · R01 · FY2022 · DK
PPAR MEDICATED GENE EXPRESSION IN HIV PATIENTS
$695,754Marie C Gelato · State University New York Stony Brook · M01 · FY2007 · RR
Proteomic determinants of direct measures of insulin sensitivity
$695,603Themistocles Leonard Assimes · Stanford University · R01 · FY2020 · DK
Implementing A QSP Platform to Predict and Test Drugs for Metabolic Associated Fatty Liver Disease Genetic Variants in an iPSC-cell Based Human Biomimetic Liver Microphysiology System
$695,586Mark T. Miedel · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DK
Epidemiology of diet, metabolism and non-alcoholic fatty liver disease in Hispanic/Latino adults
$695,447Robert C Kaplan · Albert Einstein College Of Medicine · R01 · FY2025 · DK
Maladaptive Expression of Metabolic Enzymes and Activity in Heart Failure
$695,444E Douglas Lewandowski · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · HL
Thyroid Hormone Signaling in Human Hepatocytes
$695,438Anthony N Hollenberg · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · DK
ANGPTL3 DEFICIENCY AND ATHEROSCLEROSIS IN HUMANS
$695,363Nathan Oliver Stitziel · Washington University · R01 · FY2016 · HL
Paternal Contributions to Metabolic Disease in Offspring: Environment, Epigenetics, and Sperm
$695,275Mary E Patti · Joslin Diabetes Center · R01 · FY2024 · DK
Corticosteroid Pharmacokinetics and Pharmacodynamics
$695,193William J Jusko · State University Of New York At Buffalo · R01 · FY2016 · GM
Multimodal omics approach to identify health to cardiometabolic disease transitions
$694,961Paivi Pajukanta · University Of California Los Angeles · R01 · FY2025 · HL
Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women
$694,955Andrea A. Kovacs · University Of Southern California · R01 · FY2019 · DA
Genetic and Metabolic Basis of Familial Lipodystrophies
$694,902Abhimanyu Garg · Ut Southwestern Medical Center · R01 · FY2023 · DK
Genetic and Metabolic Basis of Familial Lipodystrophies
$694,902Abhimanyu Garg · Ut Southwestern Medical Center · R01 · FY2025 · DK
Proteomic determinants of direct measures of insulin sensitivity
$694,532Themistocles Leonard Assimes · Stanford University · R01 · FY2021 · DK
Nutrient overload, insulin resistance, and hepatic mitochondrial dysfunction
$694,416Elizabeth Jane Parks · University Of Missouri-Columbia · R01 · FY2018 · DK
Glycemic and Weight Loss Effects of Semaglutide in Subjects After Spinal Cord Injury and Type 2 Diabetes
$694,221Marzieh Salehi · University Of Texas Hlth Science Center · R01 · FY2025 · DK
Fatty liver disease and its determinants in an American Indian Population: the Strong Heart Study
$694,166Shelley A Cole · Texas Biomedical Research Institute · R01 · FY2017 · DK
Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response
$694,067Brian Jesse Debosch · Washington University · R01 · FY2020 · HL
Managing Atherosclerosis by Modulating HDL Function
$693,767M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2021 · HL